Bioanalytical Laboratories

 

Phase I / Bioequivalence

About PharmaNet Laboratories
  Phase I / Bioequivalence
     
Capabilities   About Anapharm
Our Equipment   Overview
Sample Handling   Phase I Studies
Method Development and Validation
  Generic-Drug/Bioequivalence Studies
Sample Analysis
  Services
Discovery Support
  Experience
Biomarkers
  Special Populations
ELISA and RIA
  Therapeutic Areas
ICP-MS
  Equipment and Software
List of Available Assays and Biomarkers
  Project Management
Pharmaceutical and Biopharmaceutical
  Quality Assurance
Generic
  QT/Qtc Capabilities
  Clinical Laboratory
About Our Companies Clinical Pharmacology
Anapharm   Regulatory / Scientific Affairs
Anapharm Europe   Regulatory / Scientific and Medical Writing
Keystone Analytical
   
Taylor Technology    
   
Consulting   Phase II-IV
Consulting Services
  Phase II–IV Overview
   
Clinical and Product Development Services
International Regulatory Consultation   Bioanalytical Laboratory
Clinical Development Planning   Biostatastics
Global Safety and Pharmacovigilance   Data Management
Risk Management   Global Safety and Pharmacovigilance
Gap Analysis   Medical Writing
Submission Strategies   Project Management
Regulatory Liaison   Protocol / Case Report Form Design
Biostatistics   Quality Control / Assurance
Pharmacokinetics and Pharmacodynamics   Regulatory Affairs
  Risk Management
Key Product Areas Site Management
Biosimilars   Strategic Planning
Blood   Study Monitoring
Cell / Gene Therapies    
Combination Products   Specialty Areas
Drug Delivery Systems   Our Approach
Medical Devices   Dermatology
Small Molecule Drug Products   General Medicine and Cardiovascular
Therapeutic Proteins   Infectious Disease and Vaccines
Vaccines   Neuroscience
  Oncology
Business Plan Services Ophthalmology
Business Plan Services   Pediatrics
  Women's Health
Life Sciences Investments    
Life Sciences Investments   Phase IV Development
  Phase IV Development
Chemistry/Manufacturing Controls    
Regulatory Strategies   Clinical Recruitment
Implementation Consultation   Overview
  Program Branding
Quality Assurance/Quality Control Effective Database Search
SOP Development   Consistent Study Communications
FDA Inspection (GxP)   Study-Specific Web Portal
Process Validation   Professional Referal-Network Mgt
GxP Training/Audits   Program-Awareness Materials
Quality Systems Regulation   Advertising and Public Announcements
  Sample List of Deliverables
Library Additional Programs and Materials
Presentations      
Case Studies   About Us
Conference / Events  
  About PharmaNet

Technology (About PharmaSoft)

  Management Team
Office Locations
The Integral Difference of PharmaSoft
     
  Investors
Integral CDMS/CTMS
Integral CDMS/CTMS
  Overview
  Press Releases
IVRS SEC Filings
Integrated Voice Response System (IVRS)
  Stock Information
  Interactive Event Calendar
EDC Investor Services
Electronic Data Capture (EDC)
  Corporate Information
  Governance
Dictionary Coding  
Dictionary Coding
  Careers
 
Laboratory Data Management Careers
Laboratory Data Management
   
  News
Safety Data Mangement
Safety Data Management
  News
   
PharmaSoft Case Studies Investigators
1. Hybrid Data Capture  
2. Managing Patient Endpoints   Investigators
   
Support Service Study Participants
Support Services
 
  Study Participants
In-House Tools  
In-House Tools
  Contact Us
 
      Contact Us
         
         
         
         
PharmaNet Development Group, Inc.504 Carnegie Center, Princeton, NJ 08540Tel 609 951 6800Fax 609 514 0390